Navigation Links
MannKind Corporation to Hold Third Quarter Financial Results Conference Call on November 5, 2008
Date:10/29/2008

VALENCIA, Calif., Oct. 29 /PRNewswire-FirstCall/ -- MannKind Corporation (Nasdaq: MNKD) will release its 2008 third quarter financial results on Wednesday, November 5, 2008 at 8:00 a.m. EST.

Management of the Company will host a conference call to discuss the third quarter financial results, clinical progress and other Company developments at 9:00 a.m. EST on November 5, 2008. Presenting from the Company will be its Chairman and Chief Executive Officer, Alfred Mann; President and Chief Operating Officer, Hakan Edstrom; Corporate Vice President and Chief Financial Officer, Matthew Pfeffer and Corporate Vice President and Chief Scientific Officer, Peter Richardson.

To participate in the live call by telephone, please dial (888) 677-5721 or (210) 839-8507. Those interested in listening to the conference call live via the Internet may do so by visiting the Company's website at http://www.mannkindcorp.com.

A telephone replay of the call will be accessible for approximately fourteen days following completion of the call by dialing (866) 411-1707 or (202) 369-0654. A replay will also be available on MannKind's website for fourteen days.

About MannKind Corporation

MannKind Corporation (Nasdaq: MNKD) focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes and cancer. Its pipeline includes AFRESA(TM), which has completed Phase 3 clinical trials, and MKC253, which is c
'/>"/>

SOURCE MannKind Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. MannKind Unveils Proposed Trade Name at Dedication of Danbury Manufacturing Facility
2. MannKind to Present at the UBS Global Life Sciences Conference
3. MannKind Corporation Reports Second Quarter Financial Results
4. MannKind Corporation to Hold Second Quarter Financial Results Conference Call on August 11, 2008
5. MannKind to Present at Upcoming Conferences
6. MannKind Corporation Reports First Quarter Financial Results
7. MannKind to Present at the Morgan Stanley Healthcare Conference
8. MannKind Corporation to Hold First Quarter Financial Results Conference Call on May 5, 2008
9. Matthew J. Pfeffer Joins MannKind as Corporate Vice President and Chief Financial Officer
10. MannKind Corporation Response to Recent Market Events
11. MannKind Corporation to Hold Fourth Quarter Financial Results Conference Call on March 4, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... (PRWEB) May 27, 2015 Expanding in ... cement manufacturer Avalon Biomed Inc. recently inked ... Mokuda Dental Co. Ltd. , the largest endodontic ... into the international market for Avalon Biomed, which manufactures ... award-winning tricalcium silicate-based dental cements that have won renown ...
(Date:5/27/2015)... Israel , May 27, 2015  Tikcro Technologies ... quarter ended March 31, 2015. ... quarter, we continued pre-clinical work to generate functional specific ... an early stage, we are encouraged by the development ... field as new antibodies which modulate immune checkpoints gain ...
(Date:5/27/2015)... Winnipeg, MB (PRWEB) May 27, 2015 ... imaging data to combat disease, Cubresa Inc. today ... , “Our MR Compatible in-bore PET Scanner uses ... inserted into single-purpose preclinical MRI machines from manufacturers ... of Cubresa, headquartered in Winnipeg, Canada. “This enables ...
(Date:5/27/2015)... BETHESDA, Md. , May 27, 2015  Northwest ... biotechnology company developing DCVax® personalized immune therapies for cancer, ... Chief Technical Officer of the Company, will be making ... Annual Meeting in Chicago on ... CDT, at the Industry Expert Theater in McCormick Place. ...
Breaking Biology Technology:Dental Manufacturer Avalon Biomed Inks Major Deal with Japanese Distributor 2Dental Manufacturer Avalon Biomed Inks Major Deal with Japanese Distributor 3Tikcro Technologies Reports First Quarter 2015 Results 2Tikcro Technologies Reports First Quarter 2015 Results 3Cubresa Launches Simultaneous PET/MRI Technology 2NW Bio To Present Overview Of DCVax-Direct Phase I Trial In Chicago This Weekend 2NW Bio To Present Overview Of DCVax-Direct Phase I Trial In Chicago This Weekend 3
... 21 Accuray,Incorporated (Nasdaq: ARAY ), a global ... president and chief executive officer, Euan S.,Thomson, Ph.D., is ... Care Conference at the Pierre Hotel in New York ... (9:30 a.m. PST)., A live webcast of the ...
... 21 Trubion Pharmaceuticals Inc.,(Nasdaq: TRBN ) ... officer and chairman of Trubion, is scheduled to ... Markets Healthcare Investor,Conference to be held at The ... present Nov. 27, 2007, at 2:30 p.m. Interested ...
... 21 Alexza,Pharmaceuticals, Inc. (Nasdaq: ALXA ) ... live during the 19th Annual Piper Jaffray,Health Care ... p.m. Eastern,Time. The presentation will be webcast from ... under the Investor Relations tab at http://www.alexza.com ...
Cached Biology Technology:Accuray Incorporated's CEO to Speak at Piper Jaffray 19th Annual Health Care Conference 2Accuray Incorporated's CEO to Speak at Piper Jaffray 19th Annual Health Care Conference 3Trubion Pharmaceuticals to Present at the Lazard Capital Markets Healthcare Investor Conference 219th Annual Piper Jaffray Health Care Conference to Webcast Alexza's Corporate Presentation 2
(Date:5/28/2015)... , May 28, 2015 Industry analyst ... a new report titled "Markets for Self-Healing Materials: ... inorganic capsule and vascular systems, biomaterials, relevant shape ... to around $2.7 billion by 2020. ... extensive coverage of smart materials. Other recent n-tech reports ...
(Date:5/27/2015)... CLEVELAND , May 27, 2015 /PRNewswire/ ... in medication safety systems and image documentation ... provider of comprehensive, technologically-advanced automation solutions, is ... art integration. The Codonics® Safe Label System® ... used in conjunction with the Omnicell Anesthesia ...
(Date:5/26/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/p2kc6z/saudi_arabia ... "Saudi Arabia Biometric Systems Market Forecast and Opportunities, ... http://photos.prnewswire.com/prnh/20130307/600769) , ,The biometric systems market in ... grow at over 22% CAGR through 2020 ... surging demand for better biometric technologies in the ...
Breaking Biology News(10 mins):The Market for Self-Healing Materials to Reach $2.7 Billion by 2020 Says New n-tech Research Study 2The Market for Self-Healing Materials to Reach $2.7 Billion by 2020 Says New n-tech Research Study 3Codonics and Omnicell Expand Partnership 2Codonics and Omnicell Expand Partnership 3Codonics and Omnicell Expand Partnership 4Saudi Arabia Biometric Systems Market Forecast and Opportunities, 2020 with Morpho Safran, ZK Technlogy, and Suprema Dominating 2
... Scientists at the University of Maryland and Tulane University ... that is the first to address the interaction of ... research team simulated how the fish,s flexible body bends, ... around it as well as the muscles inside. Understanding ...
... at the University of Michigan Heath System and their ... one day help guide new treatments for psoriasis, one ... Using cutting-edge methods to peer into the ... the research, published in Nature Genetics, further ...
... agreement between the MPI of Biochemistry and GSK pursues ... research and development work is based on the research ... Biochemistry. He and fellow scientist Mathias Bcker successfully described ... kinases - in connection with the development of type ...
Cached Biology News:Computational model of swimming fish could inspire design of robots or medical prosthetics 2Computational model of swimming fish could inspire design of robots or medical prosthetics 3Four new psoriasis 'hotspots' identified by U-M geneticists 2Cooperation in diabetes research 2
Immunogen: Recombinant full length protein, corresponding to amino acids 1-435 of Human AP2M1. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Anti-Dynamin Monoclonal Antibody Description: 100 g Research Focus: neuroscience Storage: -20C Shipping Temperature: 4C...
cysteine and glycine-rich protein 2,...
BKBeta2 potassium channel Antigen: Fusion protein amino acids 1-41 (N-terminus) and 218-235 (C-terminus) of mouse BKBeta2 Accession Number: Q9CZM9...
Biology Products: